Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-29

Clinical Trial Update: Assessment of Efficacy and Safety of the Use of Two Eye Gel Products Containing 5% Dexpanthenol in Patients With Moderate to Severe Dry Eye Syndrome [NA]

View source ↗

Summary

A clinical trial update assessing the efficacy and safety of two eye gel products containing 5% dexpanthenol for moderate to severe dry eye disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexpanthenol Eye Gel A (dexpanthenol)
  • Dexpanthenol Eye Gel B (dexpanthenol)

Snippet

Sponsor: Fidia Farmaceutici s.p.a. | Conditions: Dry Eye Disease | NA | Status: UNKNOWN